| 1 |
22760341 | Comparison of clinical efficacy between 3-day combined clavulanate/amoxicillin preparation treatment and 10-day amoxicillin treatment in children with pharyngolaryngitis or tonsillitis. | 2013 Feb |
1 |
| 2 |
23895190 | β-Lactamase inhibitors: an update. | 2013 Nov |
1 |
| 3 |
19505232 | A sensitive coupled HPLC/electrospray mass spectrometry assay for SPM-1 metallo-beta-lactamase inhibitors. | 2009 Apr |
1 |
| 4 |
15518561 | Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant. | 2004 Nov 9 |
1 |
| 5 |
11327849 | Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam. | 2001 Feb 13 |
1 |
| 6 |
10331993 | Inhibitor resistant class A beta-lactamases. | 1999 May 15 |
1 |
| 7 |
7873581 | beta-Lactamase mutations far from the active site influence inhibitor binding. | 1995 Feb 22 |
1 |
| 8 |
8396624 | In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors. | 1993 Jun |
1 |
| 9 |
6363381 | In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species. | 1983 Dec |
1 |